Please ensure Javascript is enabled for purposes of website accessibility

Why Novavax, Range Resources, and Deutsche Bank Slumped Today

By Dan Caplinger – Sep 16, 2016 at 7:01PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These stocks led the market downward. Find out why.


Image source: Deutsche Bank.

Friday saw the stock market close the week on a negative note, and investors seemed to put their heads down and prepare for next week's much-anticipated meeting of the Federal Open Market Committee. Recently, views on likely monetary policy have become much more varied and unpredictable, and few have any confidence about what the Fed is likely to do at its September meeting.

In addition to the overall concerns about the market, some companies also had negative news that sent their stocks downward by much more than the losses of roughly half a percent or less in most major market benchmarks. Among the worst performers on Friday were Novavax (NVAX 6.10%), Range Resources (RRC 1.73%), and Deutsche Bank (DB 1.09%).

Novavax's study tells investors what they don't want to hear

Novavax plunged 85% after releasing data from two clinical trials looking at its proposed vaccine for the respiratory syncytial virus. In particular, results from the Resolve Phase 3 trial failed to meet the objectives that the company had set, including the primary objective for efficacy in lower respiratory tract disease symptoms and secondary objectives for efficacy in reducing all symptomatic respiratory disease due to the virus.

Another Phase 3 trial of the vaccine involving healthy pregnant women is ongoing, and investors hope that the results of that trial will prove to be better than the Resolve trial covering older adults. As a result, the company still believes that the vaccine could have a path forward to approval at some point, but it will have to look more closely at the results to try to figure out what went wrong.

Range Resources finishes its deal

Range Resources fell 5% in the wake of the completion of a merger. The energy company finished its purchase of Memorial Resource Development, taking on the Fort Worth exploration and production company's debt, and issuing Range Resources stock to Memorial Resource Development shareholders. For every 100 shares that Memorial shareholders owned in their company, Range Resources issued 37.5 shares of its stock in return.

Going forward, Range Resources is optimistic about the prospects of the combined companies, and CEO Jeff Ventura said that the "combination of the two highest quality natural gas plays in the United States provides Range with a strong foundation to create sustainable shareholder value." However, the all-stock nature of the deal arguably dilutes some of Range Resources' existing opportunities, and investors seemed to focus on that aspect of the deal today.

Deutsche Bank faces potential fines

Finally, Deutsche Bank dropped 9%. The German bank confirmed that it's under pressure from the U.S. Department of Justice, which is looking to impose fines of $14 billion. The fines are related to mortgage-backed securities in the lead-up to the financial crisis, and given how much in fines Deutsche Bank's U.S. counterparts in the financial industry have already paid, the amount doesn't seem that punitive.

For its part, Deutsche Bank thinks it will be able to escape liability by settling for less than the full amount, but even a greatly reduced fine could have a material impact on the bank's financial condition. Given the challenges in Europe, an attack from across the Atlantic is the last thing that Deutsche Bank needs.

Dan Caplinger has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Deutsche Bank Stock Quote
Deutsche Bank
DB
$10.65 (1.09%) $0.12
Range Resources Stock Quote
Range Resources
RRC
$28.82 (1.73%) $0.49
Novavax Stock Quote
Novavax
NVAX
$17.66 (6.10%) $1.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
351%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.